Clinical Trials Sponsored by AMG Medical Inc.

Total 3517 results

Auris Medical AG

Completed

AM-111 in the Treatment of Acute Inner Ear Hearing Loss (HEALOS)

Hearing Loss

Bulgaria
Auris Medical AG

Completed

AM-101 in the Treatment of Post-Acute Tinnitus 2 (AMPACT2)

Tinnitus

Germany
Auris Medical AG

Completed

Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus

Tinnitus

Germany
Auris Medical AG

Completed

AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery (TRAVERS)

Vestibular Vertigo

France
Auris Medical AG

Completed

AM-101 in the Treatment of Acute Tinnitus 3 (TACTT3)

Tinnitus

Germany
Auris Medical AG

Completed

Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss

Hearing Loss

Germany
Eastern Virginia Medical School
AMAG Pharmaceuticals, Inc.

Recruiting

Aspirin for the Prevention of Preeclampsia in Women With Stage 1 Hypertension

Pre-Eclampsia

United States
AMAG Pharmaceuticals, Inc.

Recruiting

A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects

Iron Deficiency Anemia

United States, Lithuania, Poland
AMAG Pharmaceuticals, Inc.

Completed

Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women

Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women

United States
AMAG Pharmaceuticals, Inc.

Terminated

A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease

Iron Deficiency Anemia

United States
AMAG Pharmaceuticals, Inc.

Completed

A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia

Iron Deficiency Anemia

United States, Canada, Hungary, India, Latvia, Poland
AMAG Pharmaceuticals, Inc.

Completed

A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and Women

Anemia

United States
AMAG Pharmaceuticals, Inc.

Terminated

A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease

Iron Deficiency Anemia

United States
Amp Orthopedics, Inc.

Terminated

Effectiveness Study of the Ivivi SofPulse for Pain Amelioration in Adults With Mild to Moderate Knee Osteoarthritis

Knee Osteoarthritis

United States
AMAG Pharmaceuticals, Inc.

Recruiting

A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

Chronic Kidney Disease; Iron Deficiency Anemia

United States, Hungary, Lithuania, Mexico, Poland
AMAG Pharmaceuticals, Inc.

Completed

A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

Iron Deficiency Anemia

United States, Canada, Hungary, Latvia, Poland, Lithuania, Puerto Rico
AMAG Pharmaceuticals, Inc.

Terminated

A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease

Iron Deficiency Anemia | Nondialysis-dependent Chronic Kidney Disease

United States
AMAG Pharmaceuticals, Inc.

Completed

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients

Anemia

United States
AMAG Pharmaceuticals, Inc.

Completed

Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran

Nausea

United States
AMAG Pharmaceuticals, Inc.

Completed

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

Anemia

United States
Amp Orthopedics, Inc.

Terminated

Impact of Noninvasive Targeted Pulsed Electromagnetic Field (tPEMF) on Opioid Use, Pain, and Joint Function Following Total Knee Arthroplasty

Osteoarthritis, Knee

United States
AMAG Pharmaceuticals, Inc.

Completed

A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease (FIRST)

Anemia | Iron Deficiency | Kidney Disease

United States, Belgium, Canada, Germany, India, Poland, United Kingdom
AMAG Pharmaceuticals, Inc.

Terminated

Study Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal Women

Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) in Healthy Post-menopausal Women

United States
AMAG Pharmaceuticals, Inc.

Completed

A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia

Iron Deficiency Anemia

Germany, Poland, United Kingdom, Australia, France, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Romania, South Africa, Spain, Ukraine
AMAG Pharmaceuticals, Inc.

Completed

A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia

Iron Deficiency Anemia

United States, Canada, Hungary, India, Latvia, Poland
AMAG Pharmaceuticals, Inc.

Completed

Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis

Iron Deficiency Anemia Treatment | Chronic Kidney Disease(CKD)

United States, Canada, United Kingdom
AMAG Pharmaceuticals, Inc.

Terminated

Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe Preeclampsia

Severe Preeclampsia

United States, Poland, South Africa
AMAG Pharmaceuticals, Inc.

Unknown

Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)

Peripheral Arterial Disease (PAD)

United States
AMAG Pharmaceuticals, Inc.

Completed

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

Anemia

United States
Amp Orthopedics, Inc.

Terminated

Effectiveness of the Ivivi Torino II, Pulsed Radio Frequency Device, on Narcotic Use, Pain and Quality of Life Following Shoulder Arthroscopic Rotator Cuff Repair.

Rotator Cuff Tear

United States
AMAG Pharmaceuticals, Inc.

Completed

A Crossover Safety Study of Ferumoxytol Versus Placebo

Anemia

United States
EndoCeutics Inc.
AMAG Pharmaceuticals, Inc.

Withdrawn

Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer

Vaginal Atrophy in Breast Cancer Patients
EndoCeutics Inc.
AMAG Pharmaceuticals, Inc.

Withdrawn

Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study

Hypoactive Sexual Desire Disorder (HSDD)

United States
Palatin Technologies, Inc
AMAG Pharmaceuticals, Inc.

Completed

2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)

Hypoactive Sexual Desire Disorder

United States, Canada
CAGE Bio Inc.
AMA Laboratories Inc.

Completed

50 Human Subject Repeat Insult Patch Test (HRIPT)

Erythema | Sensitisation

United States
University of Texas Southwestern Medical Center
AMAG Pharmaceuticals, Inc.

Terminated

Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery (APART)

Cardiovascular Disease | Anemia

United States
Perosphere Pharmaceuticals Inc, a wholly owned...
Quintiles, Inc.

Completed

A Study to Determine the Inter/Intra Observer and Intra-subject Variability of Whole Blood Clotting Time Measurements

Healthy

United States
Perosphere Pharmaceuticals Inc, a wholly owned...

Completed

Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCT

Healthy

United States
Perosphere Pharmaceuticals Inc, a wholly owned...

Completed

Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban (PER977-P1)

Anticoagulant Reversal | Reversal of Edoxaban Induced Anticoagulation

United States
Perosphere Pharmaceuticals Inc, a wholly owned...
Quintiles, Inc.

Completed

Study of PER977 Administered to Subjects With Steady State Edoxaban Dosing and Re-anticoagulation With Edoxaban

Anticoagulation Reversal

United States
Perosphere Pharmaceuticals Inc, a wholly owned...
Quintiles, Inc.

Completed

Variability of Whole Blood Clotting Time Measurements in Ex Vivo Human Blood Samples Spiked With Anticoagulants

Healthy
Perosphere Pharmaceuticals Inc, a wholly owned...

Recruiting

Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy Adults

Healthy

United States
Perosphere Pharmaceuticals Inc, a wholly owned...

Completed

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PER977 Following Heparin

Healthy

United States
Perosphere Pharmaceuticals Inc, a wholly owned...

Completed

PK and PD of Single, Escalating Doses of PER977 Following Enoxaparin (PER977)

Healthy

United States
Perosphere Pharmaceuticals Inc, a wholly owned...

Completed

Phase 2 Study of Rivaroxaban Reversal by Ciraparantag as Measured by WBCT

Healthy

United States
Altamira Medica Ltd.

Completed

Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers

Rhinitis, Allergic | Perennial Allergic Rhinitis

Canada
NC Medial Research Inc

Recruiting

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
CSA Medical, Inc.
Reset Medical, Inc.

Withdrawn

CryoSpray Ablation(tm)Thoracic Patient Registry

Asthma | Emphysema | Lung Cancer | Mesothelioma | COPD | Sarcoidosis | Chronic Bronchitis
AMAG Pharmaceuticals, Inc.
Registrat-Mapi

Completed

A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth

Children Whose Mothers Received 17P and Those Who Received Vehicle in the 17P Efficacy Trial

United States, Spain, Russian Federation, Canada, Czechia, Hungary, Ukraine
DAS-MG, Inc

Recruiting

Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia Gravis

Myasthenia Gravis

United States

3

Subscribe